|
Post by mnholdem on Aug 22, 2016 11:07:24 GMT -5
|
|
|
Post by goyocafe on Aug 22, 2016 14:53:13 GMT -5
I have a freeway overpass that I'm willing to share with him, so long as he bathes downstream...
|
|
|
Post by babaoriley on Aug 22, 2016 15:19:55 GMT -5
Gosh, you people are soooooooooooo bitter toward SNY!!
|
|
|
Post by careful2invest on Aug 22, 2016 16:43:38 GMT -5
Gosh, you people are soooooooooooo bitter toward SNY!! Do you feel differently toward Sanofi? And if so, why?
|
|
|
Post by babaoriley on Aug 23, 2016 0:52:24 GMT -5
Gosh, you people are soooooooooooo bitter toward SNY!! Do you feel differently toward Sanofi? And if so, why? Absolutely, I'm past bitter to abject hatred!
|
|
|
Post by mnholdem on Aug 23, 2016 7:05:45 GMT -5
|
|
|
Post by kc on Aug 23, 2016 9:49:07 GMT -5
Eventually Mannkind will be healthy and part of a bigger company when Afrezza becomes a blockbuster drug. Big Pharma is always looking for the new blockbuster drug or at least the cash cow staple drug. Afrezza will be one or the other. Diabetics need Insulin and Afrezza is the perfect tool for them. This article regarding the Medivation deal is spot on about Pharma looking for deals. www.fiercebiotech.com/biotech/all-bets-are-for-biotech-deals-after-14b-medivation-bonanza
|
|